Combining with the eight studies reported by Abdi et al,13 there were 179 (3.84%) germline BRCA2, 68 (1.46%) germline ATM and only 27 (0.58%) germline BRCA1 in 4664 men with metastatic prostate cancer. Here, ATM is linked to metastatic prostate carcinoma.